Viewing Study NCT00775632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-01-25 @ 9:14 AM
Study NCT ID: NCT00775632
Status: COMPLETED
Last Update Posted: 2016-06-23
First Post: 2008-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
None Bone Marrow Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Graft Versus Host Disease View
None Alemtuzumab View
None Campath View
None Bone Marrow Transplants View